Education
About Us
Working with TipRanks
Follow Us
Ascendis Pharma (ASND)
NASDAQ:ASND
ASND Analyst Ratings
Strong Buy
12 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ASND Stock 12 Month Forecast
Average Price Target
$293.33
▲(28.09% Upside)
| Highest Price Target$342.00 | Average Price Target$293.33 | Lowest Price Target$255.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Morgan Stanley
$256
Buy
11.79%
Upside
Reiterated
03/09/26
Cantor Fitzgerald
$254→$300
Buy
31.00%
Upside
Reiterated
03/04/26
Wedbush
$239→$273
Buy
19.21%
Upside
Assigned
03/04/26
Barclays
$342
Buy
49.34%
Upside
Reiterated
03/03/26
Stifel Nicolaus
$325
Buy
41.92%
Upside
Reiterated
03/02/26
Wells Fargo
$330
Buy
44.10%
Upside
Reiterated
03/02/26
Goldman Sachs
$250→$255
Buy
11.35%
Upside
Reiterated
03/02/26
RBC Capital
$250→$275
Buy
20.08%
Upside
Reiterated
03/02/26
Oppenheimer
$246→$262
Buy
14.41%
Upside
Reiterated
02/12/26
TD Cowen
$325
Buy
41.92%
Upside
Reiterated
02/11/26
Bank of America Securities
$260
Buy
13.53%
Upside
Reiterated
02/11/26
Evercore ISI
$317
Buy
38.42%
Upside
Reiterated
01/20/26
J.P. Morgan
―
Buy
―
Reiterated
11/13/25
Raymond James
$271
Buy
18.34%
Upside
Initiated
10/17/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
$256
Buy
11.79%
Upside
Reiterated
03/09/26
Cantor Fitzgerald
$254→$300
Buy
31.00%
Upside
Reiterated
03/04/26
Wedbush
$239→$273
Buy
19.21%
Upside
Assigned
03/04/26
Barclays
$342
Buy
49.34%
Upside
Reiterated
03/03/26
Stifel Nicolaus
$325
Buy
41.92%
Upside
Reiterated
03/02/26
Wells Fargo
$330
Buy
44.10%
Upside
Reiterated
03/02/26
Goldman Sachs
$250→$255
Buy
11.35%
Upside
Reiterated
03/02/26
RBC Capital
$250→$275
Buy
20.08%
Upside
Reiterated
03/02/26
Oppenheimer
$246→$262
Buy
14.41%
Upside
Reiterated
02/12/26
TD Cowen
$325
Buy
41.92%
Upside
Reiterated
02/11/26
Bank of America Securities
$260
Buy
13.53%
Upside
Reiterated
02/11/26
Evercore ISI
$317
Buy
38.42%
Upside
Reiterated
01/20/26
J.P. Morgan
―
Buy
―
Reiterated
11/13/25
Raymond James
$271
Buy
18.34%
Upside
Initiated
10/17/25
Best Analysts Covering Ascendis Pharma
3 Months
xxx
Success Rate
20/26 ratings generated profit
Average Return
+10.76%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +10.76% per trade.
1 Year
Success Rate
30/32 ratings generated profit
Average Return
+32.23%
reiterated a buy rating last month
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 93.75% of your transactions generating a profit, with an average return of +32.23% per trade.
2 Years
xxx
Success Rate
26/26 ratings generated profit
Average Return
+61.43%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +61.43% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ASND Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
2
2
6
7
6
Buy
36
30
33
28
36
Hold
7
7
18
12
27
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
45
39
57
47
69
Each month's total comprises the sum of three months' worth of ratings.
ASND Financial Forecast
ASND Stock Forecast FAQ
What is ASND’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascendis Pharma’s 12-month average price target is 293.33.
What is ASND’s upside potential, based on the analysts’ average price target?
Ascendis Pharma has 28.09% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ASND a Buy, Sell or Hold?
Ascendis Pharma has a consensus rating of Strong Buy which is based on 12 buy ratings, 0 hold ratings and 0 sell ratings.
What is Ascendis Pharma’s price target?
The average price target for Ascendis Pharma is 293.33. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $342.00 ,the lowest forecast is $255.00. The average price target represents 28.09% Increase from the current price of $229.01.
The highest analyst price target is $342.00 ,the lowest forecast is $255.00. The average price target represents 28.09% Increase from the current price of $229.01.
What do analysts say about Ascendis Pharma?
Ascendis Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of ASND?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.